Hyperbaric Oxygen and curcumin stabilises woman with myeloma

Hyperbaric Oxygen and curcumin stabilises woman with myeloma

A 57-year old woman with recurrent Multiple Myeloma since 2007 had the usual drugs and saw her myeloma slowly progress. She was stage 3 when she decided to add a daily single dose of 8 gms of curcumin and a once-weekly course of Hyperbaric oxygen. The curcumin contained biopiperine (which makes the curcumin even more powerful and helps absorption). She took it on an empty stomach (although a little olive oil might have helped the absorption even more).

 

Her multiple myeloma then stabilised. Over the following 5 years she only took curcumin and her myeloma has remained stable, her blood counts are in the normal range, and there has been minimal fluctuation in her paraprotein levels. In effect this is a cure.

 

The British Medical Journal, reporting on this case study(1), talks of curcumin being a natural antioxidant, anti-inflammatory, antiseptic and analgesic. It is known to prevent myeloma cell proliferation in vitro. A full blown study has now been recommended.

 

Chris Woollams, former Oxford University Biochemist and founder of CANCERactive said, “Was she a CANCERactive reader? Hyperbaric Oxygen is one treatment we have championed; and curcumin is one of our favourite natural compounds. Many of my Personal Prescription patients are encouraged to use both. There is a website in the USA called ‘Margaret’s corner’ where the writer has help her smouldering myeloma at bay for a dozen years or so. So the use of curcumin is not news to us. When one UK patient was told not to take it by her oncologist because it would block the chemo drugs, we produced a short report showing seven clinical trials where it actually does the opposite. It helps some chemotherapy drugs work, it kills cancer cells in its own right, it reduces cancer-proliferating inflammation in the body and it helps protect healthy cells. It is high time some UK oncologists and dieticians, wised up to bioactive natural compounds.”

 

 

 

Ref

  1. BMJ Case Reports 2017; doi:10.1136/bcr-2016-218148

 

 

 

 

2018 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.